08/22/2025
3:06 PM | Hill Stephen J. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2025
3:02 PM | Lee Gary K. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2025
3:03 PM | Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2025
11:15 PM | Lyell Immunopharma (Filer)
| Form EFFECT | |
08/13/2025
8:10 PM | Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2025
8:06 PM | Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2025
8:08 PM | Lee Gary K. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2025
8:09 PM | Hill Stephen J. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2025
3:49 PM | Lyell Immunopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/12/2025
3:13 PM | Lyell Immunopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2025
11:15 PM | Lyell Immunopharma (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for LYEL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lyell Immunopharma and its competitors with MarketBeat's FREE daily newsletter. |
07/29/2025
8:23 PM | ARCH Venture Fund XIII, L.P. (Reporting)
ARCH Venture Partners XIII, L.P. (Reporting)
ARCH Venture Partners XIII, LLC (Reporting)
BERNS PAUL L (Reporting)
Burow Kristina (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
Lyell Immunopharma (Issuer)
NELSEN ROBERT (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/29/2025
8:25 PM | ARCH Venture Fund IX Overage, L.P. (Reporting)
ARCH Venture Fund IX, L.P. (Reporting)
ARCH Venture Partners IX Overage, L.P. (Reporting)
ARCH Venture Partners IX, L.P. (Reporting)
ARCH Venture Partners IX, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
Lyell Immunopharma (Issuer)
NELSEN ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2025
7:05 AM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2025
3:20 PM | Lyell Immunopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/26/2025
3:07 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2025
7:49 AM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
4:48 PM | Bachleda Mark (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:38 PM | Lyell Immunopharma (Issuer)
Shook David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2025
4:40 PM | Lyell Immunopharma (Issuer)
Meltz Mark A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2025
4:42 PM | Bachleda Mark (Reporting)
Lyell Immunopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2025
4:45 PM | Lyell Immunopharma (Issuer)
Shook David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:47 PM | Lyell Immunopharma (Issuer)
Meltz Mark A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:23 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2025
5:41 PM | Lyell Immunopharma (Issuer)
Ramachandra Sumant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:43 PM | Lyell Immunopharma (Issuer)
NABEL ELIZABETH G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:45 PM | BRAWLEY OTIS W (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:47 PM | FRIEDMAN CATHY (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:48 PM | Lyell Immunopharma (Issuer)
RIEFLIN WILLIAM JL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:50 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
3:39 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
3:41 PM | Lyell Immunopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/10/2025
3:55 PM | Lyell Immunopharma (Filer)
| Form PRE 14A | |
04/02/2025
2:46 PM | BRAWLEY OTIS W (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
4:01 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
5:46 PM | Lyell Immunopharma (Issuer)
Ramachandra Sumant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
7:07 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
6:01 PM | Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:59 PM | Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:52 PM | Lyell Immunopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2025
6:27 PM | Lee Gary K. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad) Right now, we’re witnessing a monumental shift in the world. Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia. |
02/26/2025
6:29 PM | Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:31 PM | Hill Stephen J. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:33 PM | Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:36 PM | Lang Matthew (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Lyell Immunopharma (Subject)
| Form SCHEDULE 13G/A | |
01/24/2025
3:39 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
8:10 AM | Lyell Immunopharma (Filer)
| Form 8-K/A | |
12/09/2024
8:03 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
7:39 AM | Lyell Immunopharma (Filer)
| Form 424B5 | |
12/05/2024
11:15 PM | Lyell Immunopharma (Filer)
| Form EFFECT | |
11/29/2024
3:19 PM | Lyell Immunopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/26/2024
3:05 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:30 PM | Lyell Immunopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:54 PM | Lyell Immunopharma (Issuer)
Ramachandra Sumant (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2024
3:56 PM | Lyell Immunopharma (Issuer)
Ramachandra Sumant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
5:00 PM | Foresite Capital Fund IV, L.P. (Filed by)
Lyell Immunopharma (Subject)
| Form SC 13G | |
10/31/2024
3:45 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:06 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access